Thioridazine

*Thioridazinum*

For medical students2 min readUpdated 2026-10-10

Thioridazine is an antipsychotic medication that stands out significantly among the classical representatives of its pharmacological group. Unlike most traditional neuroleptics, it does not cause severe sedation and possesses a unique ability to alleviate depressive states, making its action profile quite specific.

Spectrum of actionAntipsychotic and sedative effects are weaker than those of chlorpromazine

UniquenessExhibits a pronounced antidepressant effect in endogenous depressions

ReceptorsDisplays significant anticholinergic activity

High dosesCan exhibit specific cardiotoxic effects

ToxicityHigh doses carry a risk of retinal degeneration (retinopathy)

Spectrum of Psychotropic Activity

When studying thioridazine, medical students must first remember that its classical antipsychotic potency is inferior to reference drugs. Compared to chlorpromazine, both the antipsychotic and sedative effects of thioridazine are significantly weaker.

However, this weakness is compensated by crucial features that determine the clinical value of the drug:

Lack of suppression: Patients do not experience the typical lethargy, pronounced somnolence, and feeling of psychological depression commonly seen with neuroleptics.
Antidepressant effect: This is a unique property of thioridazine. Unlike many other antipsychotics that can trigger or worsen depression, thioridazine acts as an antidepressant itself. It has proven efficacy in treating endogenous depressions.

Safety Profile and Side Effects

The side effects of thioridazine are closely tied to its receptor profile. The drug has pronounced anticholinergic activity, which must be taken into account when prescribing therapy.

On the other hand, this drug has a significant advantage in the motor domain. Compared to other neuroleptics, thioridazine is characterized by a minimal risk of extrapyramidal symptoms (movement disorders that plague classical antipsychotic therapy). This makes it a safer choice for patients sensitive to motor side effects.

Specific Toxicity in Overdose

Despite its favorable extrapyramidal profile, thioridazine requires strict dosage control. Using the drug in high doses is fraught with the development of severe specific toxicity.

This primarily affects two target organs:

Heart: The drug exhibits cardiotoxic effects, which can lead to serious cardiovascular disturbances.
Eyes: Long-term administration of high doses carries the risk of damaging the visual apparatus, specifically causing retinal degeneration (retinopathy).

Mnemonic

Remember thioridazine through the 'THREE NOs': NO extrapyramidal symptoms, NO drowsiness and lethargy, NO depression (since it treats endogenous depression itself). But beware of high doses: they hit the HEART and EYES (retinopathy).

Frequently asked questions

To which chemical group of antipsychotics does thioridazine belong?

Thioridazine belongs to the class of typical antipsychotics (neuroleptics). Chemically, it is a phenothiazine derivative and is part of the piperidine subgroup. Other piperidine derivatives include periciazine and pipotiazine. This group is characterized by moderate antipsychotic activity, a moderately pronounced sedative effect, moderate anticholinergic activity, and a lower incidence of extrapyramidal symptoms compared to chlorpromazine.

What are the main indications for thioridazine besides endogenous depressions?

Besides endogenous depressions, the drug is used to treat a wide range of psychiatric, neurological, and somatic disorders. Key indications include:

Behavioral correction — in psychopathies, neuroses, and organic diseases.
Affective disorders — treatment of anxious and agitated depression.
Somatoform disorders — therapy for autonomic dystonia.
Suicidal risk — in the first days of therapy to calm the patient.
Alcohol dependence — to correct irritability and reduce cravings.
Obsessive-compulsive neurosis — for monothematic stereotyped fears.
Somatic disorders — treatment of pruritus due to its antihistamine effect.

What are the absolute contraindications to prescribing thioridazine?

An absolute contraindication to prescribing thioridazine is the presence of anticholinergic psychosis or delirium tremens in the patient. Furthermore, the drug is strictly contraindicated for managing substance intoxication and related psychoses. These limitations are due to thioridazine's pronounced anticholinergic activity. Its use in these states creates a high risk of severely potentiating psychotic symptoms, especially if the patient abused anticholinergics.

What is the main difference in the psychotropic action of thioridazine compared to chlorpromazine?

Thioridazine has weaker antipsychotic and sedative effects than chlorpromazine. At the same time, it does not cause the characteristic lethargy, depression, and somnolence.

Can this drug be used for depressive states?

Yes, this is its unique property. Thioridazine possesses intrinsic antidepressant effects and is effectively used in endogenous depressions.

What is the probability of developing extrapyramidal symptoms?

Unlike most other neuroleptics, the risk of developing movement disorders (extrapyramidal symptoms) with thioridazine is minimal.

What severe complications occur with high doses?

High doses of thioridazine lead to specific toxicity: marked cardiotoxic effects and a risk of retinal degeneration (retinopathy).

Go deeper

Comparison of thioridazine and chlorpromazine pharmacodynamics
Correlation between anticholinergic activity and the absence of extrapyramidal symptoms
Mechanisms of neuroleptic-induced cardiotoxicity
Endogenous depression as an indication: why do antipsychotics work?
Retinal degeneration in drug-induced toxicity